femasys(FEMY) - 2024 Q2 - Quarterly Results

Exhibit 99.1 Femasys Announces Financial Results for Quarter Ended June 30, 2024 and Provides Corporate Update -- Company gained CE Mark approval for four of its women's health products and completed buildout of commercial team for its infertility portfolio -- ATLANTA, August 8, 2024 -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of in-office, accessible and innovative therapeutic and diagnostic products, a ...